Prior studies in gastric, lung, and cervical cancers have suggested that ASF1B modulates cell cycle regulators such as Cyclin E1, CDK2, and MYC, consistent with our enrichment results showing associations with DNA replication and mitotic pathways [21]. This evidence concerns the gene MYC and cervical carcinoma.